Skip to content

Evaluation of Efficacy and Safety of Ialuset Cream and Gauze in Second-degree Burns on Child

Observational Retrospective Study Evaluating Efficacy and Safety of Ialuset Cream or Gauzepad in Second Degree Burns Use for Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04124133
Enrollment
92
Registered
2019-10-11
Start date
2018-12-10
Completion date
2019-04-18
Last updated
2019-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Second-degree Burn of Children

Brief summary

Observational retrospective monocentric study occured in the univeristy hospital center of Bensançon the department of pediatric surgery. Data of patients treated in the hospital between January 2016 and January 2019 have been collected.

Detailed description

Coordinator investigator have put in place a protocol care for children with second degree burns since 2016. It consists in detersion and cleaning of wound, application of ialuset cream and gauzepad (hyaluronic acid) during 21 days. After 21 days if patients are not healed, physician consider to perform grafting

Interventions

DEVICEdressing with hyaluronic acid

Application of ialuset cream or gauzepad (hyaluronic acid)

Sponsors

Laboratoires Genévrier
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to 15 Years

Inclusion criteria

* second-degree burns * less than 20% of the body surface * less than 15 years old * treated within 24 hours * 1st line of treatment with ialuset * treated at the center between 2016 and 2019

Exclusion criteria

* patient who refused data collection

Design outcomes

Primary

MeasureTime frameDescription
Patient rate with complete healing21 dayspourcentage of patient with 100% of reepithelilisation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026